Aller au contenu principal
Profil bibliographique

Jose Trevino

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

44Publications signalées
708Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Pancreatic and Hepatic Oncology ResearchNutrition and Health in AgingCancer, Hypoxia, and MetabolismCancer Genomics and DiagnosticsCancer, Stress, Anesthesia, and Immune Response

Les publications récentes

Accès ouvert 2025 article OpenAlex

Robotic Whipple for Abnormal Pancreaticobiliary Junction With Recurrent Acute Pancreatitis: A Case Report

Adam Khader, Beth Rider, Catherine Frakes Vozzo, Munazza Anis et autres

Pancreaticobiliary maljunction (PBM) is a congenital anomaly that predisposes patients to recurrent pancreatitis, choledocholithiasis, and an increased risk of biliary tract malignancy. In patients without biliary dilatation, standard management typically consists of cholecystectomy with endoscopic biliary decompression. However, management can be challenging …

us (code pays fourni par la source)

0 citations Cureus
2025 conference-abstract OpenAlex

Abstract 3196: CRTAM defines effector functionality and robust anti-tumor response of cytotoxic CD8+T cells

Zheng Liu, An Nguyen, Amy L. Olex, Mikail Bala et autres

Abstract The effectiveness of current cancer immunotherapies, such as immune checkpoint blockade (ICB), adoptive T cell therapy (ACT), and chimeric antigen receptor (CAR) T-cell therapy, is limited in solid tumors due to the scarcity of tumor-specific immunogenic targets, impaired tumor antigen processing, …

us (code pays fourni par la source)

0 citations Cancer Research
2025 conference-abstract OpenAlex

Abstract 4904: Say it ain’t psoas: addressing edema in pancreatic cancer body composition analyses

Evan W. Davis, Margaret A. Park, Toni L. Basinski, J. Pablo Arnoletti et autres

Abstract Background: Image based body composition is the gold standard for assessing skeletal muscle area and quality in cancer patients. In patients with pancreatic ductal adenocarcinoma (PDAC), the decrease in muscle area and quality can be particularly profound. Yet image-based muscle assessment …

us (code pays fourni par la source)

0 citations Cancer Research
2025 conference-abstract OpenAlex

Abstract 4324: Inhibition of ERK reactivation by FGTI-2734: A strategy to overcome sotorasib resistance in KRAS G12C lung cancer

Aslamuzzaman Kazi, Hitesh Kumar Kantilal Vasiyan, Deblina Ghosh, Dipankar Bandyopadhyay et autres

Abstract Discovery of sotorasib is a major breakthrough for KRAS G12C targeted therapies. However, overall response rates of patients with KRAS G12C lung cancer treated with sotorasib are modest due to resistance mediated by adaptive reactivation of ERK, which requires wild-type (WT) …

us (code pays fourni par la source)

0 citations Cancer Research
2025 conference-abstract OpenAlex

Abstract 5162: Decreases in blood pressure in a patient-derived xenograft model of pancreatic ductal adenocarcinoma

Amelia R. Malicki, Leslie M. Ogilvie, Alexa N. King, Patrick Sanosa et autres

Abstract Introduction: Chemotherapy and radiation treatment cause cardiac injury and dysfunction. It remains unclear how cancer affects cardiac structure and function in therapy-naïve mice. Emerging data shows that epithelial ovarian cancer affects hemodynamics by causing cardiac atrophy, intrinsic cardiac dysfunction and arterial …

ca, us (code pays fourni par la source)

0 citations Cancer Research
2025 conference-abstract OpenAlex

Abstract 3047: Glycan-targeted therapy for effective treatment of pancreatic cancer

Erica J. Peterson, Vignesh Vudatha, Vashti L. Bandy, Praveen Bhoopathi et autres

Abstract Patients with the most common pancreatic malignancy, pancreatic ductal adenocarcinomas (PDAC), typically present with advanced disease and their cancer progresses 6-12 months after treatment with the front-line regimen, FOLFIRINOX (5-fluorouracil, oxaliplatin, irinotecan and leucovorin). Therefore, there is a critical need for …

us (code pays fourni par la source)

1 citation Cancer Research
2025 conference-abstract OpenAlex

Abstract 5158: Establishing novel patient-derived xenograft models for peritoneal metastasis in a racially diverse population

Vashti L. Bandy, Adam Khader, Praveen Bhoopathi, Vignesh Vudatha et autres

Abstract Colorectal cancer (CRC) is highly treatable when localized, but survival drops sharply with metastasis, especially to the peritoneum (PM). CRC PM is particularly resistant to chemotherapy, emphasizing the need for models that replicate disease biology for use in drug discovery. Our …

us (code pays fourni par la source)

0 citations Cancer Research
2025 conference-abstract OpenAlex

Abstract 49: Genetic, genomic, and pharmacologic characterization of a new cohort of ancestrally diverse patient-derived xenograft models of cancer

Nina M. Dashti-Gibson, Amy L. Olex, Katarzyna M. Tyc, Carson J. Walker et autres

Abstract Introduction: Patient derived xenografts (PDX) are important preclinical models of cancer as they faithfully recapitulate many aspects of human tumors. Currently, models derived from patients of non-European genetic ancestry are underrepresented, limiting the potential of precision medicine advancements to equitably improve …

us (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2025 article OpenAlex

Somatic Genomic Profiling of Pancreatic Ductal Adenocarcinomas From a Diverse Cohort of Patients

Andrea N. Riner, Enrique I. Velazquez-Villarreal, Seeta Rajpara, Jing Qian et autres

OBJECTIVES: Black/African American (B/AA) pancreatic ductal adenocarcinoma (PDAC) patients have worse clinical outcomes than White patients and are underrepresented in genomic databases. We aimed to expand our understanding of the PDAC somatic landscape from a diverse cohort. MATERIALS AND METHODS: Formalin-fixed paraffin-embedded …

us (code pays fourni par la source)

11 citations Pancreas
Accès ouvert 2024 article OpenAlex

FGTI-2734 Inhibits ERK Reactivation to Overcome Sotorasib Resistance in KRAS G12C Lung Cancer

Aslamuzzaman Kazi, Hitesh Vasiyani, Deblina Ghosh, Dipankar Bandyopadhyay et autres

INTRODUCTION: KRAS G12C targeted therapies, such as sotorasib, represent a major breakthrough, but overall response rates and progression-free survival for patients with KRAS G12C lung cancer are modest due to the emergence of resistance mechanisms involving adaptive reactivation of ERK, which requires …

us (code pays fourni par la source)

8 citations Journal of Thoracic Oncology
Accès ouvert 2024 article OpenAlex

Robotic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is there a benefit?

Brian K. Sparkman, Devon C. Freudenberger, Vignesh Vudatha, Jose Trevino et autres

BACKGROUND: Open cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a therapeutic option for the management of malignancies with peritoneal carcinomatosis and of peritoneal origin. Robotic surgery shows promise as a minimally invasive approach for select patients. We aimed to evaluate …

us (code pays fourni par la source)

6 citations Surgical Endoscopy
Accès ouvert 2024 article OpenAlex

Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma

Jennifer B. Permuth, Margaret A. Park, Dung‐Tsa Chen, Toni L. Basinski et autres

Introduction: Cancer-associated cachexia (CC) is a progressive syndrome characterized by unintentional weight loss, muscle atrophy, fatigue, and poor outcomes that affects most patients with pancreatic ductal adenocarcinoma (PDAC). The ability to identify and classify CC stage along its continuum early in the …

us (code pays fourni par la source)

19 citations Frontiers in Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.